Detalhe da pesquisa
1.
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Br J Haematol
; 200(2): 175-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214090
2.
Pyoderma gangrenosum induced by lenalidomide in a case of multiple myeloma.
Ann Hematol
; 99(2): 379-380, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31822948
3.
Adult patients with de novo acute myeloid leukemia show a functional deregulation of redox balance at diagnosis which is correlated with molecular subtypes and overall survival.
Haematologica
; 104(9): e393-e397, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30819920
4.
High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS study.
Br J Haematol
; 162(2): 240-9, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23692641
5.
Two new alpha-thalassemia point mutations that are undetectable by biochemical techniques.
Hemoglobin
; 32(4): 411-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18654892
6.
A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhibitor, in patients with polycythemia vera or essential thrombocythemia.
Leuk Res
; 60: 11-17, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622623
7.
[Multidisciplinary team meetings in cancerology: setting priorities for improvement]. / Évaluation des réunions de concertation pluridisciplinaire en cancérologie : quelles priorités pour quelles améliorations ?
Bull Cancer
; 98(9): 989-98, 2011 Oct.
Artigo
em Francês
| MEDLINE | ID: mdl-21908262
8.
Therapeutic impact and diagnostic performance of multiplex PCR in patients with malignancies and suspected sepsis.
J Infect
; 61(4): 335-42, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20637801
9.
Multifocal polyclonal Epstein-Barr virus-associated B-cell lymphoproliferative disorder secondary to azathioprine therapy successfully treated with rituximab.
Leuk Lymphoma
; 51(1): 174-7, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20001240